Genomics England PacBio Prelim Q4 Revenues up 33 Percent; Firm Partners With Google, Berry Genomics, Genomics England PacBio reported preliminary Q4 revenues of $36 million and full-year revenues of about $130.5 million, both falling short of analyst estimates. Whole-Genome Sequencing Shines for Rare Disease Diagnosis in 100K Genomes Pilot Study Researchers diagnosed 25 percent of rare disease cases in a whole-genome sequencing pilot study of almost 2,200 patients and thousands more family members. People in the News: New Appointments at Genomics England, Seven Bridges, Dante Labs, More LifeArc Providing £5M for COVID-19 Study on Genomics of Severe Disease The grant, to support the work of the GenOMICC consortium, will help to identify genetic factors associated with response to the virus. European Project Sets Out to Harness Genomics Data, AI to Create New Predictive Tools Premium Called Intervene, the project will use genomic and health data from biorepositories along with machine learning methods to develop new clinical predictive tools. Jan 29, 2021 Genomics England Preps for NHS Genomic Medicines Service Launch With New Focus, Tools Premium Sep 28, 2020 UK Government Unveils New Genomic Healthcare Strategy Jul 2, 2020 Genomics England, Sano, Zetta Building Platform to Support Rare Disease Patient Participation Premium May 12, 2020 Illumina, UK Agencies Partner on £28M Sequencing Study of COVID-19 Patients Apr 24, 2020 National Genomics Programs in UK, US Change Data Storage Calculations Premium Jan 14, 2020 Illumina, Genomics England Ink Deal to Sequence up to 300K People May 28, 2019 Silence Therapeutics Inks Deal to Access Genomics England Database Mar 21, 2019 Genomics England, AI Startup Collaborate on Immunotherapy Dec 19, 2018 French Medical Genomics Initiative's Pilot Sequencing Platforms Set to Commence Operations Premium Oct 4, 2018 Genomics England Taps Iqvia for Clinical-Genomic Data Integration Jun 1, 2018 UK's NHS Prepares Transition to Diagnostic Genome Sequencing for Rare Diseases, Some Cancers Premium Jan 8, 2018 Genomics England Adopts Edico's Dragen For NGS Analysis Nov 6, 2017 As 100K Genomes Project Returns Patient Reports, NHS Prepares to Commission WGS for Diagnostics Premium Oct 19, 2017 Fabric Genomics Announces Multiple Pediatric Medicine Initiatives; Edico Genome Partnership Oct 17, 2017 Global Alliance for Genomics and Health Releases Strategic Plan, Announces Driver Projects Premium Sep 1, 2017 Independent Report Urges UK Support for Genomics, Other Life Sciences Jun 26, 2017 Genomics England to Adopt Illumina's BaseSpace Variant Interpreter for Cancer Samples May 17, 2017 Denmark to Make Genomic Data Centerpiece of New $14.2M Personalized Medicine Initiative Premium Feb 27, 2017 Congenica Eyes US, Chinese Markets, Plans Product Upgrades Following $10M Financing Round Premium Feb 27, 2017 UK Genomic Analysis Firm Congenica Raises $10M Load More Breaking News NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.